Saint Luke's Newsroom

DEFINE-HF was not only the first multi-center randomized placebo-controlled clinical trial that Saint Luke’s developed, coordinated, and implemented in its entirety, but the first significant effort to look at what effect dapagliflozin, a drug initially created for the treatment of diabetes, was going to have in patients who also have heart failure.  

September is National Suicide Prevention Month. Amanda Davis shares how to open the conversation with teens and children, as well as what stressors can trigger harmful thoughts with Better Kansas City.  

Mumps cases are on the rise, and a new study says even people who are vaccinated may still get the virus. KCTV talked to Dr. Todd Fristo to find out if parents should be concerned.

Saint Luke's Muriel I. Kauffman Women's Heart Center is celebrating its 25th year serving the Kansas City community and taking a proactive role in addressing women's heart health.

Saint Luke’s cardiologist James O’Keefe, MD, co-authors new study published in Mayo Clinic Proceedings.

Lucas Schubert, Nutritional Coordinator with Saint Luke's Mid America Heart Institute and the Food As Medicine Everyday (FAME) program, shares how to make easy Turkey Avocado Roll-ups and other healthy lunch options as kids go back to school with the FOX4 morning show. 

After a serious crash in rural Missouri, Mark Carr felt at ease in the hands of the Saint Luke's Hospital of Kansas City trauma team.

There is now new hope for people who have suffered life-altering injuries in the region. FOX4 talked to one patient who came to Saint Luke's for her rehabilitation care after suffering multiple aneurysms and a stroke.

Saint Luke's Rehabilitation Institute, a new state-of-the-art neurorehabilitation facility in Overland Park, was unveiled to the public Thursday.